2022-07-27 OMA Agenda - Board of Trustees

Board of Trustees Meeting July 27, 2022

7:00-8:00 PM ET/6:00- 7:00 PM CT/5:00-6:00 PM MT/4:00-5:00 PM PT Join ZoomMeeting https://obesitymedicine-org.zoom.us/j/85002721511?pwd=TnNiQTFpT2d4VHhkWlF2NC9iclI4Zz09 Presiding: Ethan Lazarus, MD, FOMA, President Time Topic Lead Action Doc # 5:00 PM Call to Order, Opening Remarks, Rules of Order for Board Meetings Lazarus Order 1 5:03 PM Roll Call Bays 5:05 PM Approval of the Agenda Lazarus Decision 5:07 PM Conflict of Interest Disclosures Bays Declarations 5:12 PM Consent Agenda • Minutes 04/27/2022 Lazarus Vote 2

Vote

Nominating Committee Slate Approval Election Timeline Deadline changes Board of Trustees Election Campaign Rules

5:15 PM

Fitch, Fraker

3,4,5

Discussion

Review of OMA Spring Meeting 2022 Feedback/Surveys & BOT’s Role in Educational Content Development Summary/Updates from Roadblocks to Obesity Care Roundtable Meeting (6/17-19, 2022) and Edits or Endorsement of Obesity Consensus Statement Among Obesity-Specific Societies

Fraker

6

5:20 PM

Discussion, Vote

Fitch, Fraker

7,8

5:35 PM

Information

5:45 PM

Update re: Dr. Bill McCarthy & Dr. Abby

Fraker

Bays

5:47 PM

Obesity Pillars Announcements/E-mails

9

Next EC Meeting (4-6 weeks; set date/time)

Lazarus

5:55 PM

6:00 PM

Lazarus

Adjourn

Call to Adjourn and Closing Remarks

Rules of Order Policy Board Approved September 2017

Rules of Order for Board Meetings

Quorum: Our bylaws state that a quorum is present if the majority of the board is present.

Order of the day: Each meeting will have an agenda which will include points to discuss, old business and new business. The leader of the meeting is referred to as the “Chair.” This may be the chairman of the board, the president, or the highest-ranking officer present at the meeting. Items to discuss: All board members may submit items to discuss. These items must be submitted at least 2 weeks prior to the scheduled meeting. Items must be submitted electronically as editable Microsoft word documents. Items must include: the person (or persons, committee, etc.) introducing the item and the date of submission. Items should be marked as informational items (board updates), discussion items (not asking for action), or action items. For action items, the specific action being requested by the board should be clearly indicated. Late items: From time to time, items of critical importance may need to be introduced within 2 weeks of the board meeting. These items will be marked in the board book as “Late” and will only be discussed after a majority vote of the board to discuss the item. 1) The chair may call on the person responsible for the next order of business. Or, when no one else has the floor, a board member may address the chair by proper title. After recognition by the chair, the board member may make a motion. 2) To make a motion, state, “I move that…,” and state your motion. For example, “I move that we discuss item #4 regarding updating our travel policy…” Regarding the above items of business, the person who introduced the item o f business and who’s name appears on the item of business should introduce the motion. 3) Another member may second your motion. A second simply means that the motion should be discussed. If the motion is not seconded, it is not up for discussion. It is not lost, as there has been no vote. 4) Only if there is a second, the chair states “It has been moved and seconded that…” (state the motion). “Is there any discussion?” 5) Only one main motion may be on the floor at a time. Discussing a motion 1) All speaking points should be limited to 3 minutes. This will be enforced with a timer, and an OMA staff person will be designated to monitor the timer. A different time limit (or no time limit) may also be used if requested by a majority of the quorum, either for a single item of business, or for the entire meeting. 2) The member who made the motion is entitled to speak to it first. 3) Every member may speak to the motion. Only the motion at hand should be spoken either for or against. Each member should clearly state whether they are speaking for or against the motion. 4) A person may not speak against their own motion (however, they can vote against their own motion). 5) All discussion should be directed towards the motion. Avoid using a person’s name during the de bate. 6) All questions should be directed to the chair. 7) Each member may only speak to the motion twice; however, asking a question or a brief suggestion does not count as that person’s debate. Motions: Introducing a main motion

Rules of Order Policy Board Approved September 2017

8) A person may only speak a third time with the chair’s permission. 9) Only the person who introduced the motion may speak again at the end (even if this is a third time).

Voting on a motion 1) Before a vote is taken, the Chair puts the question to a vote by saying “Those in favor of the motion that… (repeat the motion) … say ‘Aye.’ Those opposed say ‘No.’” 2) Wait, then say “The motion is carried,” or “The motion is lost.” 3) If a member is in doubt about the result, he or she may call for “division.” A division is a demand for a standing vote count. This may be show of hands or ballot. 4) A majority is MORE than ½ of the votes cast by persons entitled to vote (a tie does NOT carry because it is not a majority). 5) A confidential written vote may be requested by any member of the board during in-person meetings. This would not require a second. Amending a motion a. Any main motion or resolution may be amended by: adding at the end, striking out or inserting words, substitution. b. To amend a motion, during discussion, a member may say “I move to amend the motion by…” Another member must second this amendment. c. The chair asks “Is there any discussion on the amendment? [repeat amendment].” At this point, only the amendment is discussed. d. When discussion ceases, the Chair says “Those in favor of the amendment [repeat amendment] s ay ‘Aye.’ Those opposed say ‘Nay.’ e. At this point, the motion carries or not. The main motion (amended or not) can now be voted on, discussion can continue, or the motion may be amended again (by another motion). f. Note, even if an amendment is passed, the main motion has still not been voted on – a separate vote is required. 2. Postpone definitely / indefinitely a. When the assembly does not want to take a position on the main question at all (indefinitely) b. When the assembly wants to delay to a certain time (definitely) 3. Motion to substitute a. When the assembly wishes to substitute a new motion for the original motion. 4. Refer a. Sends a pending motion to a committee, etc. 5. Limit debate / Extend debate 6. Lay the motion on the table (tabling the motion) a. This is used to lay the pending question aside and move on with other business. This may be appropriate when there is a more urgent question at hand, scheduling issue (people invited to speak to the board), etc. Privileged Motions 1. Call for order of the day – a member can interrupt a speaker to call for sticking with the agenda. 2. Recess – used to request an intermission (does not end the meeting) Subsidiary Motions 1.

Rules of Order Policy Board Approved September 2017

3.

Adjourn – used to end the meeting.

4. Fix the time to Which to Adjourn – sets the time at which the meeting will adjourn; any unfinished business is moved to the next meeting.

Incidental Motions 1. Point of order – used when member feels rules are being violated. Member may interrupt a speaker to raise a point of order. 2. Appeal – used to challenge the chair’s ruling. 3. Suspend the rules – example – suspend the time limit, allow other discussions, etc. 4. Withdraw – permits the maker of the motion to withdraw it. 5. Point of information – requests to the chair to provide information relevant to business at hand. A point of information must be in the form of a question. 6. Objection to consideration of a question – suppresses business that is irrelevant or inappropriate and undesirable to be discussed. Other Main Motions 1. Take from the table – resumes consideration of a motion laid on the table earlier. 2. Reconsider – reopens a motion to debate that has already been voted upon in the same session. 3. Rescind or amend – something previously adopted Carefully review the complete board manual before the board meeting. 2. Communicate prior to the meeting – Many items can be resolved before the meeting, saving valuable time. Or, big ticket items can be identified and proper time allocated. 3. Freedom of movement – Board members are welcome to stand, sit, or use the facilities as needed. 4. Freedom of opinion – Board members are free to express their opinions, without fear of stigmatization or personal attack by other board members. 5. Respect – Board members are expected to treat each other respectfully. 6. Attention – Board members are expected to pay attention. This requires turning off cell phones and other distracting electronic devices. Board members are expected not to be texting, emailing or making personal calls (barring emergency or urgent situations) during meetings. 7. Conflict of interest – If a real or perceived conflict exists, a board member must disclose this. Depending on the conflict, if the other board members feel the conflict is not germane to the item being discussed, the member may be allowed to discuss and vote. Other options – member may be allowed to discuss but not vote. Member may be not allowed to discuss or vote. Or, member may be asked to leave the board room for the discussion. The board should determine the level of conflict and appropriate level of involvement by the conflicted member on the issue at hand. Other Rules of Conduct: 1. Be prepared –

Board of Trustees Meeting Minutes—April 27, 2022 Call to Order: The board meeting was called to order at 1:02PM (EDT) by Dr. Ethan Lazarus Roll Call: Dr. Harold Bays, Secretary/Treasurer Attendees : Drs . Craig Primack, Ethan Lazarus, Marisa Censani, Lydia Alexander, Ms. Sandra Christensen, Drs. Michelle Freshwater, Angela Fitch, Harold Bays, Anthony Auriemma, Suzanne Cuda, Bharti Shetye, and Carolynn Francavilla Brown. Teresa Fraker (OMA Executive Director and Ms. Dana Stifter (Operations and Governance Manager). Jim Wilson (Legal Counsel), Doctors William McCarthy and Carl Knopke joined the call for specific agenda items. Approval of Meeting Agenda: Motion to accept Meeting Agenda The motion passed Consent Agenda Consent agenda included minutes from Board of Trustees meeting from 1/13/2022 and other Class II Documents. Motion to accept Consent Agenda The motion passed Recognition of Dr. William McCarthy Dr. William McCarthy was added to this meeting via Zoom. Dr. McCarthy is stepping down from his role with OMA and the board thanked him personally for his years of service. Treasurer’s Report Mrs. Teresa Fraker reviewed the current year 2022 budget, and where OMA currently stands for its operating budget as well as the current membership data. Dr. Harold Bays discussed his Treasurer Resource Document and how it should be utilized going forward. Dr. Lazarus suggested an edit on page #39, first sentence. The current sentence reads “…. shall annually distribute…”, and should read, “ may annually distribute...”. Dr. Bays agreed with the change, Ms. Fraker will make change in document. Discussion took place regarding the Investment Policy, which was authored and edited by through Stifel, OMA’s investment firm. This document provided thorough explanation of how

1

OMA utilizes this policy to ensure that safe practices are followed for the investments and finances of OMA. Motion to accept the Investment Policy The motion passed Motion to edit and add date to Investment Policy and Motion to edit and delete section C & D from the Investment Policy The motion passed Discussion on Sunset Policies and the review process and who reviews these policies. The Policy Committee will be tasked with reviewing these policies annually. *Action item – Clarification on Item D Asset Mix and percentages for cash reserve and cash equivalent. Motion to Approve the amended Investment Policy The motion passed **Dr. Censani was not present during this discussion Bi-Annual Meeting versus Annual Meeting(s) Proposal Ms. Teresa Fraker discussed the current meeting schedule and the effects of having two large meetings a year on OMA, particularly with reference to costs associated with two large meetings per year. Her recommendation is that OMA move to a larger spring meeting (also known as the “Spring Main” Meeting) beginning in the Spring of 2024, that would more align with the ABOM Diplomate Review Course and the ABOM Diplomate application process, as the ABOM Examination will occur each fall, beginning in the Fall of 2022. The board discussed the meeting schedule and agreed to have a larger spring annual meeting, with a smaller focused fall meeting beginning in Spring of 2024. In conjunction with this change, the board leadership election schedule would also need to change, as it would affect board members terms being extended. Currently, OMA rotates it board leadership each fall, and with this proposed shift, the OMA board leadership would rotate in the spring of each year instead, which necessitates an amendment to the bylaws to provide for this. Under this bylaws amendment, the 2022 board leadership will be installed in Fall of 2022 and remain in office until Spring of 2024. Motion to amend Bylaws The motion passed It is to be reflected in the minutes that the board is directing the Executive Director to retain two in-person meetings a year, with the spring meeting functioning as the “Spring Main” meeting and the second meeting functioning as a “Focused Fall” meeting. The “Focused Fall”

2

meeting will likely be much more abbreviated (such as over a weekend) and focused on a specific patient population or disease state. Motion to amend section 4.07 of the Bylaws and accept the proposed Bylaw change that was presented to the board. The motion passed Motion to amend the Ethics Committee Charter and add the following to section II: Notwithstanding anything in the charter to the contrary, due to a transition in our meeting schedule, these terms will be adjusted to coincide with the amended Bylaws on 4/27/2022. The board may adjust the election cycle and terms with respect to members of the Committee, to alter terms to coincide with the annual membership meeting schedule. The motion passed Motion to accept the Proposed Election Term Changes The motion passed Ethics Presentation [PRIVILEGED AND CONFIDENTIAL] Dr. Carl Knopke, Chair of the Ethics Committee, joined the meeting via Zoom. Dr. Knopke discussed a recent complaint that the Ethics Committee had received, including the leadership of the Ethics Committee meeting with the complainant to discuss their concern(s). After the leadership of the Ethics Committee met with the complainant and provided information, the complainant dropped the complaint and the Ethics Committee concluded that no further action was necessary other than brining the matter to the OMA board to discuss the general topic of the OMA conflict of interest process. The board discussed the matter, including the OMA Conflict of Interest disclosure process, the Ethics Committee Charter and related issues. The OMA board, after discussion and consideration of the facts and circumstances, determined that no changes to the OMA Conflict of Interest disclosure process were necessary. Although the complaint already was retracted by the complainant, for purposes of clarity of the OMA board’s thoughts on the matter, the following motion was made: Motion to dismiss the complaint The motion passed Motion to investigate, with OMA’s legal counsel, if further language needs to be included in the Ethics Charter that would allow for someone to retract a perceived complaint against the actions of the board, versus an individual. The motion passed

3

Finance Committee Appointment Doctors Anthony Auriemma and Lydia Alexander have volunteered to sit on the finance committee with the Treasurer for 2022. Motion to accept the two board members to the Finance Committee

The motion passed General Information

Ms. Teresa Fraker presented the board with recommendations for increases in pricing for attendees for the Fall 2022 Conference. Discussion was had on the various levels of attendees, and the proposed increases. The Board agreed to the increased pricing for all levels, except for Clinicians in Training (CIT) membership level. *Action item – Ms. Fraker will re-evaluate the increase for CITs and get back to the board with proposed registration pricing as to whether to increase this pricing or keep the pricing as is for the CIT membership level. The CoreLifeMD group approached Dr. Nicholas Pennings who oversees OMA Clinical Education and this group would like OMA to open educational training and confer certificates to offer a separate certificate of training for Allied Health Professionals. The board agreed that this would be acceptable, and the title on such a certificate title should be, “Allied Health Professional Certificate of Education in Obesity Medicine” such that there was differentiation between this certificate and the current NP/PA “Certificate of Advanced Education”. Obesity Pillars Updates Dr. Harold Bays updated the board on OMA’s scholarly journal, Obesity Pillars and the successes that it is realizing. Future Direction of the Obesity Algorithm Discussion on the future of the Obesity Algorithm, and how to best support it moving forward. Motion to Create an Adult Obesity Algorithm Committee or Task Force The motion passed Motion to appoint Dr. Justin Tondt as Committee Chair The motion passed Dr. Michelle Freshwater will be the board liaison for this committee. Charter recommendations need to be submitted prior to the Fall 2022 Conference and include how committee members and contributors will be seated. AMA Updates Dr. Ethan Lazarus advised the board on his resolution to AMA on creating an Obesity Task Force. Dr. Lazarus will be presenting at the 2022 Annual AMA meeting directly after the OMA Strategic Retreat. Ms. Fraker updated the Board on the upcoming Strategic Retreat.

4

Nominating Committee Slate for 2022 Elections Dr. Angela Fitch advised the board on her recommended appointments to the Nominating Committee for the upcoming election. Motion to approve Nominating Committee Roster The motion passed 12-0 Quality Measure Development (via the National Quality Forum/NQF) Dr. Angela Fitch explained the advantages of being a member of the Core Quality Measures Collaborate, CQMC which is a group of experts dedicated to developing core measures for specific disease states under the NQF. Motion to join CQMC The motion passed Motion to appoint Dr. Angela Fitch to represent OMA The motion passed The Network for Excellence in Health Innovation Participation (NEHI) participation for OMA Dr. Angela Fitch proposed OMA becoming a sponsor of the NEHI project. The board discussed sponsorship and participation. Motion for sponsorship to the NEHI Roundtable, with a grant of $5,000. The motion passed NP/PA Bylaws Change Proposal Discussion was had regarding changing the structure of the NP/PA membership due to membership numbers and growth. *Action item--Ms. Fraker will investigate other organizations and how they handle this type of membership. New Business As the election cycle will be changing with the Bylaw changes, the election calendar will need to change for 2023. Motion to approve the election calendar for 2023, with two-week latitude on dates currently reflected in the nomination calendar. The motion passed **See Conflict of Interest Disclosures as below** Additional conversation on Conflict of Interest Disclosures, having a more public policy on disclosures, and collaboration with other groups. Conflict of Interest Disclosures : **Dr Anthony Auriemma disclosed he has been hired as a paid speaker for the Vivus Dine

5

Around during the OMA 2022 Atlanta Conference. Dr. Angela Fitch disclosed that she would be participating on the planning committee for Obesity Week 2022.**

Call to Adjourn Motion to Adjourn meeting at 5:17PM ET The motion passed

6

2022 OMA Election Slate Executive Committee

Position

Candidates Lydia Alexander

Designation

President-Elect

MD, FOMA

Vice President

Harold Bays

FOMA, FTOS, FACC, FNLA, FASPC MD, FOMA, Dipl. ABOM

Secretary/Treasurer

Marisa Censani

Trustee

Candidate

Designation MD, JD, FOMA

Anthony Auriemma Lilliam Chiques Suzanne Cuda

MD

MD, FOMA, FAAP, ABOM certified

Leslie Golden

MD, MPH MD, DABOM MD, MPH

Sylvia Gonsahn-Bollie

Vivek Gupta Shagun Bindlish

MD, FACP, Dipl ABOM, Dipl ACLM

Catherine (Cate) Varney Courtney Younglove

DO, ABOM

MD, FOMA, FACOG

Ethics Committee

Candidate

Designation

Michelle Alencar Jonathan Parker Robert Smythe

PhD, CCN, NBC-HWC, ACSM-EP, CPT

DO, MS, FAAFP, ABOM

MD

2022 Timeline (Approved)_

TIMELINE

Deadline

Call for applications included in eNewsletter/launch Deadline to submit application/COI to OMA office

5/2/2022 5/23/2022 6/1/2022 6/22/2022 6/29/2022 7/6/2022 7/18/2022 8/22/2022 8/25/2022 8/27/2022 5/2/2022 5/23/2022 6/1/2022 6/22/2022 6/29/2022 7/27/2022 8/5/2022 9/2/2022 9/9/2022 9/14/2022

Nominating Committee Call: discuss interview process / assign callers Deadline for Committee Members to submit written / verbal eval

Nominating Committee Call to discuss candidates Proposed ballot sent to Board for approval

Elections open to Membership

Voting period ends

Deadline for Tallying Votes

Notification to those elected and not elected

2022 Timeline (Proposed)

TIMELINE

Deadline

Call for applications included in eNewsletter/launch Deadline to submit application/COI to OMA office

Nominating Committee Call: discuss interview process / assign callers Deadline for Committee Members to submit written / verbal eval

Nominating Committee Call to discuss candidates Proposed ballot sent to Board for approval

Elections open to Membership

Voting period ends

Deadline for Tallying Votes

Notification to those elected and not elected

Board of Trustees Election Campaign Rules Approved May 29, 2019

Board of Trustees Election Campaign Rules These Obesity Medicine Association (“OMA”) Candidate Campaign Rules (the “Rules”) for Board of Trustees elections outline the activities by which candidates can campaign for a position as an OMA Officer or member of the OMA Board of Trustees (the “OMA leadership”). OMA leadership elections are collegial competitions, and candidates for such positions may engage only in positive campaigning. As such, OMA will not tolerate any negative campaigning and has the authority to remove candidates from the election process if violations occur. A carefully considered nominations and election process has been established in the OMA Bylaws. Each candidate shall have an opportunity to provide requested information about their qualifications and interests in serving in the respective OMA leadership position they are seeking. Such information shall be reviewed and approved by the OMA Nominating Committee and Executive Director and will accompany the electronic ballot when disseminated to the membership. E.g., Current activities of candidates in acknowledged competitive professional societies or associations, such as active board of trustee memberships in competitive organizations, may lead to disqualification of candidacy. Failure to abide by these rules may result in the OMA Board of Trustees taking remedial action, including, without limitation, suspending the election process, declaring the ineligibility of a candidate, or other remedial action. Candidate Campaign Materials Campaign materials shall mean any document, electronic transmission, object, or other information and materials that has the purpose or effect of promoting the candidacy of an individual for an OMA leadership position. As applicable, all campaign materials must carry an identification of their source. Production and distribution of campaign materials constitute campaign activities, and actual expenses incurred must be by the candidate, not OMA or any third party or via direct or indirect sponsorship of the candidate by a third party. Campaign materials shall refrain from including any negative remarks as to the other candidates or the OMA or OMA staff and shall not contain any lude or offensive illustrations or language in promoting the candidate. The OMA will provide each verified candidate with a candidate’s web presence created by OMA staff that features the following for each candidate nominated that the nominee would be required to provide equally: 1. Candidate Campaign Rules 2. OMA Conflict of Interest Policy and Disclosure Rules 3. Photo of the candidate 4. Biographical information listed on the leadership application 5. A Personal Candidate Statement (no more than 500 words) that provides insight in the candidates personality and opinions regarding the following: a. Tell your peers who you are in regards to your current role and position held and your professional aspirations. b. Why do you want to become an OMA Board of Trustee member, and why do you think you would make an effective and collegial OMA Board of Trustee member? c. Do you know what the OMA’s current goals and objectives are, and what are your top 3 goals and objectives that you see most important for the OMA to accomplish and why? d. How do you think your talents and skills will best serve the OMA and its members? e. Why do you have a passion for obesity medicine? 6. Possible candidate conflicts of interest and disclosures as submitted on the OMA Conflict of Interest Policy and Disclosure Statement

OMA Policy on Using Social Media for Campaigning Candidates for OMA leadership positions may use their own social media websites and applications such as, but not limited to, Facebook, Twitter, YouTube, and LinkedIn to campaign. However, candidates are not allowed to campaign on any OMA social media sites, including the OMA LinkedIn Group. At no time will the OMA provide anyone with member or non-member contact information, social media profiles, or any other contact channel information. All campaign contacts will have to be obtained by the candidates on their own accord. Endorsements of Candidates

Candidates for OMA leadership positions cannot claim to be endorsed by third parties. Under these Rules, Candidates, OMA Members, or Other Third Parties May Not: • Use or purchase OMA membership lists for campaigning purposes • Engage in false or misleading campaign activities

• Utilize confidential information or violate other OMA policies in campaign activities • Pursue blast or bulk e-mails, blast or bulk-faxes, or bulk mailing for campaigning purposes • Campaign during any CME activities • Engage in any form of negative campaigning, including speaking about an opponent, disparaging the opponent in any way, or encouraging others to do the same • Use or distribute OMA funds to support, publicize, or encourage support or endorsement, or to oppose the candidacy of an individual or group of individuals • Lend the use of OMA facilities or conference locations, such as office space, equipment, supplies, or official letterhead of OMA, to support or oppose the candidacy of an individual or group of individuals • Use the OMA logo or any other OMA trademark or intellectual property to promote a candidate for office, or on any related campaign material • Give a gift or anything of value to an OMA member in exchange for a vote or endorsement for selected office at any time • Use third-party funds or sponsorship funds to promote the candidate or their candidacy in any way

OMA SPRING 2022 (ATLANTA, GA) OVERALL CONFERENCE EVALUATION DATA

Based on your experience, how likely would you be to recommend an OMA conference to a friend or colleague? Most likely Very likely Somewhat likely Slightly likely Not likely Percentage: 82.6% 14% 2.7% 0.2% 0.5% Based on the above data, if we use the top 2 results as promoters and the bottom 3 results as detractors, our NPS is 92

How would you rate the OMA conference in the following areas? Extremely Satisfied Very Satisfied Somewhat Satisfied

Not Satisfied

Slightly Satisfied

Keynote/General Session content

71.8%

19.9%

6.1%

1.2%

1.0%

Educational session content

63.7%

23.8%

10.6%

1.0%

0.8%

Networking opportunities

51.8%

19.9%

20.2%

5.1%

3.0%

Quality of exhibitors

45.0%

28.0%

22.9%

2.2%

1.9%

Value for the money

52.8%

33.7%

11.1%

1.7%

0.7%

SPECIFIC SESSION/SPEAKER EVALUATION DATA

Rate the extent to which your knowledge of the topic has increased after this lecture

Relevance of Content

Number of responses

Quality of Speaker's Delivery

Demonstrated Experiential Knowledge

Event Average

Event Average

Event Average

to Your Practice

Event Average

First Name

Last Name

Session Title

Track

Keynote Session: Reset & Recharge: Discover Mindset & Productivity Habits That Reduce Stress, Burnout & Negativity, So You Can Enjoy Your Work & Life Again

232

4.77

Betsy

Allen Manning

4.62

4.78

4.74

4.23

4.45

4.34

4.53

OMA Clinical Practice Statement Updates

Harold

Bays

Proficiency

74

4.44

4.62

4.69

4.74

3.97

4.45

4.42

4.53

Carl

Lavie

Masters

165

4.50

4.62

4.82

4.74

4.48

4.45

4.31

4.53

Obesity and Obesity Paradox and Cardiovascular Disease

Devika

Umashanker

Proficiency

142

4.72

4.62

4.83

4.74

4.57

4.45

4.51

4.53

Incorporation of Very Low-Calorie Diet in Patient Care Setting Obesity is a Risk Factor for Chronic Kidney Disease and Kidney Stones

Masters

88

4.44

4.62

4.83

4.74

4.68

4.45

4.36

4.53

Ganesh

Shidham

Angie

Golden

Top Ten Obesity Myths

Proficiency

131

4.66

4.62

4.72

4.74

4.27

4.45

4.50

4.53

Stephen

Hermann

Masters

90

3.84

4.62

4.46

4.74

3.68

4.45

3.49

4.53

Development and Validation of the 18-item Health Resilience Profile

Obesity & Black Women: What Are We Missing?

Sylvia

Gonsahn-Bollie

Proficiency

95

4.90

4.62

4.93

4.74

4.70

4.45

4.73

4.53

Improving Physical Activity in People with Obesity and Physical Limitations

Michelle

Look

Masters

128

4.93

4.62

4.93

4.74

4.79

4.45

4.81

4.53

Jennifer

Seger

Proficiency

136

4.73

4.62

4.81

4.74

4.48

4.45

4.69

4.53

The Essentials of Anti-Obesity Medications - A Case-Based Approach

Carolynn

Francavilla

Masters

74

4.61

4.62

4.63

4.74

4.33

4.45

4.25

4.53

Treatment Strategies for Obesity Before, After, and During Pregnancy

Managing Obesity-Related Complications

Sandra

Christensen

Proficiency

95

4.57

4.62

4.78

4.74

4.40

4.45

4.62

4.53

Catherine

Varney

Masters

99

4.53

4.62

4.65

4.74

4.41

4.45

4.62

4.53

Multidisciplinary Discussion on Complex Patient Cases

229

4.87

4.62

4.91

4.74

4.63

4.45

4.72

4.53

Jason

Fung

Keynote Session: Intermittent Fasting - DeMystified

The Role of Physical Activity in Weight Maintenance and Health

Tim

Church

Proficiency

78

4.80

4.62

4.82

4.74

4.55

4.45

4.73

4.53

Nutrition and Cancer

Jason

Fung

Masters

138

4.86

4.62

4.82

4.74

4.67

4.45

4.59

4.53

4.62

4.76

4.74

4.55

4.45

4.24

4.53

Proficiency

52

4.53

Eileen

Chaves

Disordered Eating in Pediatric Obesity: What to Do and How to Help?

Masters

158

4.89

4.62

4.92

4.74

4.75

4.45

4.78

4.53

Louis

Aronne

Future Advances in Anti-Obesity Medications

Ruchir

Patel

Proficiency

43

4.18

4.62

4.69

4.74

4.28

4.45

4.38

4.53

Sleep and Obesity: Why You Should be Cognizant of the Two

Cate

Varney

Masters

162

4.19

4.62

4.47

4.74

4.18

4.45

4.40

4.53

Management of Peri & Postmenopausal Weight Gain

Jill

Ratanaphruks

Proficiency

45

4.00

4.62

4.38

4.74

3.93

4.45

4.12

4.53

Cultural Considerations for Treating Asians with Abdominal Obesity Prescriptive Nutritional Intervention Using Meal Replacements: Evidence and Case Based Practical Approaches

Angela

Fitch

Masters

145

4.83

4.62

4.89

4.74

4.55

4.45

4.58

4.53

Tailoring a Nutrition Plan to Your Patient

Ethan

Lazarus

Proficiency

54

4.80

4.62

4.96

4.74

4.63

4.45

4.76

4.53

Applying Precision Medicine in Choosing an Anti-obesity Medication: A case-based approach Complexity of Obesity, Diabetes and Depression: Which One to Address First? Obesity, Billing, Coding & Reimbursement: Get paid for the work that you do Use of Telehealth in Obesity Management: Current Evidence and Future Directions

Andres

Acosta

Masters

135

4.76

4.62

4.86

4.74

4.65

4.45

4.60

4.53

Nowreen

Haq

176

4.02

4.62

4.62

4.74

4.05

4.45

4.37

4.53

Katie

Queen

173

4.78

4.62

4.78

4.74

4.48

4.45

4.58

4.53

John

Batsis

152

4.45

4.62

4.62

4.74

4.23

4.45

4.35

4.53

Stop Weight Bias

Joe

Nadglowski

107

4.78

4.62

4.85

4.74

4.36

4.45

4.69

4.53

Roadblocks to Obesity Care Roundtable Meeting Notes 6/18-19/2022 Dallas, TX

List of Attendees/Representative Organizations:

Name

Organization

Title/Role

Dr. Tony Comuzzie Dr. Teresa LaMasters

The Obesity Society (TOS) American Society for Metabolic & Bariatric Surgery (ASMBS) Academy of Nutrition & Dietetics (AAND) Obesity Action Coalition (OAC)

CEO

President

Hollie Raynor

Board of Director Member

Joe Nadglowski

CEO

Dr. Joe Northup

ASMBS

Executive Committee Member Board of Directors Chair Director/Chief Medical Officer President-Elect

Patty Nece

OAC OMA

Dr. Angela Fitch

Dr. Bill Dietz

STOP Obesity Alliance

Dr. Dan Bessesen Hannah Martin Teresa Fraker Kristie Kaufman Cristy Gallagher

TOS

President

AAND

Director, Legislative & Government Affairs

OMA

CEO

ASMBS

Interim Executive Director Senior Center Administrator

STOP Obesity Alliance

Below are the five areas (buckets) that the group agreed upon as our objectives and the associated next action steps: 1) Communication/developing a framework for talking about obesity to the public -- STOP/OAC co-lead - 3 sub-areas: a) Defining of obesity and consensus statement (Bill lead); b) PSA domain (OAC lead); c) How to deal with disinformation/angry public (OAC lead) 2) Access to care --OAC/AND/Chris G. will lead - identify the barriers, define what we want, then act on those sub-areas: state legislative focus, large employers, plans/payers, government coverage to act as a clearinghouse function as well as a playbook function. 3) Identify partners and track who we are talking to --STOP (Cristy) will take lead putting together a Google doc that will serve as a database of potential partner organizations and contacts; and a separate document of organizations we are all presenting to and doing outreach to currently.

4) Education --TOS/OMA (Angela, Bill, and Dan) will lead; the objective is to bring together the chairs of education committees of each organization and the task is to tell us what each organization is doing in medical education and who your partners are in this space. The objective would be to come up with areas where our organizations could work together collaboratively in these efforts. 5) Research --TOS will lead - bring together a small group to make a list of the research questions that would be instrumental to get us to “advocacy informed research”; then advocate for funding to NIH/CMS innovation center/RWJ/PCORI/ARPA-H, etc. to fund research; goal is to develop a central entity that lifts up the research questions and do an annual check in to see if these questions are being answered (include SBM, CDC as a partner) • The group is asked to review their notes/minutes & send copies to Cristy for collating together • The group is asked to identify a leader for each bucket/strategy area • Cristy/Tony will arrange for the group to have a call in August to reconnect and bring up any areas we missed or that need clarification • Each bucket leader will be responsible for their workgroup developing a timeline and identifying tasks to do by November (that might be meeting with representatives from just the five groups, or it may include adding representatives at the leaders’ discretion) • Reconvene the main group (& others as interested) for a meeting via Zoom/in person at the TOS Annual Meeting on 11/1/2022. Next Steps

Consensus statement on obesity as a disease Obesity is a chronic disease characterized by excessive fat accumulation or distribution of fat that presents a risk to health. Virtually every system in the body is affected by obesity. Other major chronic diseases associated with obesity include diabetes, heart disease, and cancer. The body mass index (weight in kg/height in meters 2 ) is used to screen for obesity, but it does not replace clinical judgement, as BMI is not a measure of body fat. Patients’ race, ethnicity, and age may modify the risk associated with a given BMI. Bias and stigmatization directed at people with obesity contributes to ill health and impairs treatment. Ethan Proposal: The World Health Organization (WHO) states that: “Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health. A body mass index (BMI) over 25 is considered overweight, and over 30 is obese. The issue has grown to epidemic proportions, with over 4 million people dying each year as a result of being overweight or obese in 2017 according to the global burden of disease.” Virtually every system in the body is affected by obesity. Other major chronic diseases associated with obesity include diabetes, heart disease, and cancer. Consistent with the WHO’s statement on BMI, “BMI provides the most useful population-level measure of overweight and obesity as it is the same for both sexes and for all ages of adults. However, it should be considered a rough guide because it may not correspond to the same degree of fatness in different individuals.” Therefore, while the BMI is used to screen for obesity, it does not replace clinical judgement, as BMI is not a measure of body fat. Patients’ race, ethnicity, and age may modify the risk associated with a given BMI. Bias and stigmatization directed at people with obesity contributes to ill health and impairs treatment. Every person with obesity must have access to evidence-based treatment.

Every person with obesity deserves access to evidence-based treatment.

OBESITY PILLARS: MONTHLY NOTIFICATIONS TO OMA MEMBERS Harold Bays MD

Editor in Chief Obesity Pillars

Proposal: Once a month, the Obesity Medicine Association should send an email notification to OMA members, solely dedicated to Obesity Pillars and its articles.

Rationale:

• The first box of the recently crafted and approved Obesity Medicine Association Strategic Plan noted a goal to increase OMA recognition as “the most respected, recognized, and cited source on obesity diagnosis and treatment.” Two of the agreed upon strategies to achieve this goal were: o Scientific Outreach – OMA is the recognized venue for publication of new research relevant to clinical obesity care in Obesity Pillars o Journal Expansion – Expand the impact of Obesity Pillars • Currently, while journal activities are sometimes briefly mentioned in various OMA emails to members, dedicated emails solely regarding Obesity Pillars to OMA members are restricted to quarterly notifications. Monthly notification of societal journal activity is commonplace and standard among other medical organizations with societal journals. • By the end of 2022, Obesity Pillars will have published approximately 20 Clinical Practice Statements and multiple roundtable discussions. When other medical societies create a single clinical practice statement or guideline, each single CPS or guideline is often heavily promoted via multiple emails from the society. In contrast, no single OMA CPS or discussion has received heavy promotion. • Unless readers go to the Obesity Pillars website, or unless they signed up to be on the Obesity Pillars notification list, then because member notification of journal activity is restricted to quarterly notifications, the impact of Obesity Pillars is also being restricted. • Monthly notifications of Obesity Pillars activity would help achieve goals and strategies of the OMA strategic planning committee: o Improved recognition of Obesity Pillars as the venue for research relevant to clinical obesity care o Expand the impact of Obesity Pillars o Enhancement of the appeal of OMA to both academic and nonacademic obesity medicine specialists – thus potentially increasing OMA membership • Concurrent with each month’s notification of OMA membership of Obesity Pillars activities should be a discussion with OMA’s public relation’s firm. Obesity Pillars has published, and will continue to publish many novel articles worthy of issuing press releases and general public notifications via the press. As it stands, as Editor-in-Chief of Obesity Pillars, I cannot recall a single conversation with the OMA PR firm regarding any of the many CPS, roundtable discussions, and articles published by Obesity Pillars. This approach is not consistent with how other medical societies publicize their journal and content. Similarly, I cannot recall a single CPS or roundtable author being contacted by the OMA PR firm to discuss these articles.

• Beyond the reasons discussed at the OMA strategic planning committee, reasons to “expand the impact of Obesity Pillars” are to: o Notify OMA members of quality CPS content that might help improve the care of patients with obesity o Notify OMA members of quality roundtable content that might help improve the care of patients with obesity o Facilitate article submissions from OMA members--a major priority for long-term journal success o Facilitate article submission from OMA corporate sponsors--a priority for long-term journal success o Enhance OMA membership by establishing Obesity Pillars as the premier journal for obesity medicine clinicians